


Healthcare Industry News: C20
News Release - December 17, 2009
El Camino Hospital's Genomic Medicine Institute to Be Featured at First Personalized Medicine Conference in Silicon Valley
Acting Director Dr. Paul Billings to Give Featured AddressMOUNTAIN VIEW, Calif.--(HSMN NewsFeed)--El Camino Hospital today announced that Paul R. Billings, MD, PhD, FACP, FACMG, acting director and chief scientific officer of the Genomic Medicine Institute (GMI) at El Camino Hospital and an internationally recognized authority on genetic testing, will be presenting at Silicon Valley’s first-ever Personalized Medicine World Conference (PMWC2010). El Camino Hospital, the first community hospital to offer a personalized medicine solution, also will be gold sponsor of the event, which will be held at the Computer History Museum in Mountain View January 19-20, 2010.
“Personalized medicine has arrived, which is an exciting development for patients, particularly here in Silicon Valley where people expect the most advanced technology to be available,” says Dr. Billings, who will be providing an update on the progress El Camino’s GMI has made to date. “Through our Genomic Medicine Institute, El Camino Hospital intends on becoming the leading center nationwide in the delivery of personalized care to patients.”
Dr. Billing’s featured presentation, “From Bench-Top to Bedside: Speeding Personalized Medicine’s Translation,” will describe the challenges faced in delivering biologically tailored tests and treatments, and illustrate how the GMI at El Camino Hospital is innovating and collaborating to improve and speed personalized medicine’s translation from bench-top to bedside.
“I’m pleased that in the past year, the GMI has been able to establish cutting-edge personalized medicine solutions for physicians and patients,” Dr. Billings says.
One of the most innovative projects at the GMI is the new Family History Initiative, an effort to capture medical histories and information for entire families. “Analyzing this information and providing controlled access to family members and their physicians will help our patients and their kin receive individualized care,” says Dr. Billings.
PMWC2010 has been much anticipated in the medical community. “We’re particularly excited about this conference because it brings together some of our current partners, thought and industry leaders to discuss developments in genomic medicine,” notes Billings.
The conference topics such as:
- the impact of new genomic and proteomic technologies on diagnostics and therapeutics in cancer and other major diseases
- new challenges policy makers and regulators are facing in order to keep up with rapid advances and availability of new molecular tests
- how established biotechnology and pharmaceutical companies are adopting their strategies to incorporate personalized medicine
The sessions begin at 8:30 a.m. both days of the conference (Jan. 19-20, 2010). For more information and to register, please visit http://pmwC2010.com/.
Source: El Camino Hospital
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
